Related Experiment Video

Updated: Jun 6, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Targeted therapy for squamous cell carcinoma of the head and neck

Ibrahim T Aldoss1, Apar Kishor Ganti

  • 1The Department of Internal Medicine, Creighton University Medical Center, Omaha, NE, USA.

Journal of the Egyptian National Cancer Institute
|November 9, 2010
PubMed

Insights

Targeted therapies targeting epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) show promise for head and neck squamous cell carcinoma (SCCHN). This review explores emerging targeted agents for SCCHN treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Squamous cell carcinoma of the head and neck (SCCHN) has seen limited survival improvements.
  • SCCHN is characterized by overexpression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF).
  • These receptors and their downstream pathways represent potential therapeutic targets.

Purpose of the Study:

  • To review targeted therapies currently under investigation for SCCHN.
  • To highlight the role of EGFR and VEGF as therapeutic targets in SCCHN.

Main Methods:

  • Literature review of targeted therapies for SCCHN.
  • Analysis of studies evaluating agents targeting EGFR and VEGF pathways.

Main Results:

  • Targeted agents demonstrate a promising impact in various tumors.
  • EGFR and VEGF overexpression in SCCHN have prognostic value.

Conclusions:

  • Targeted therapies offer a novel approach to SCCHN treatment.
  • Further evaluation of these agents is crucial for improving patient outcomes.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...